Integrity and Compliance

The Office for the Vice President for Research and Innovation provides services and support for a variety of integrity and compliance functions, both for researchers and for the campus more broadly. We continually work to promote a culture of integrity and compliance, enabling the UO community to be successful in their interactions with human subjects in research, animals in research, responsible conduct of research, and allegations of research misconduct.

The Associate Vice President for Research Integrity can be reached at avprintegrity@uoregon.edu. More information about the responsibilities and actions associated with integrity and compliance are provided below.


This section contains pages with information about managing:

  • Allegations of Research Misconduct: Definitions regarding what represents misconduct, how to report concerns, and the processes associated with those reports. 
    • Allegations of Research Misconduct may be reported to the University of Oregon’s Research Integrity Officer (RIO). The RIO at the UO is currently Sheryl Johnson, Director of Research Compliance Services (sherylj@uoregon.edu).
  • Animal Research: Policies and procedures for working with animals in research
  • Conflicts of Interest and Commitment: Policies and procedures for engaging in activities outside the UO
  • Export Controls: Procedures for adhering to federal regulations that govern items and information that UO employees may share with non-U.S. citizens
  • Financial Conflicts of Interest in Research: Policies and procedures for engaging in activities outside the UO when the employee has sponsored research
  • Human Remains: Our statement on human remains outlines our principles and processes governing the use of human remains at the University of Oregon.
  • Human Subjects Research: Policies and procedures for working with human participants in research, including whether projects require review by our institutional review board.
  • Institutional Biosafety Committee: The Institutional Biosafety Committee (IBC) is delegated primary responsibility for the safe use of recombinant or synthetic nucleic acid molecules as required by Section IV-B-1 of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (hereafter referred to as the NIH Guidelines.
  • Responsible Conduct of Research: Principles, training, and education for conducting research with integrity

Report a Concern about Research